Resolving Botanicals Deadlock 'Not A Priority' For European Commission
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
You may also be interested in...
Europe’s self-care industry has “learned its lessons,” particularly in terms of securing the pharmaceutical ingredient supply chain, and will come out of the coronavirus pandemic stronger, insisted AESGP president Birgit Schuhbauer at the BAH’s High-Level Conference on Future Drug Supply in the European Union.
Five years in the making, the European Commission delivers its assessment of the botanical ingredients in food supplements situation, suggesting that 'traditional use' may be a way out of the deadlock.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Manoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”